FDG-PET response in the normal lung for lung cancer patients receiving fractionated radiotherapy and erlotinib

A. Abravan, I. Knudtsen, H. Eide, O. Brustugun, A. Helland, E. Malinen

Research output: Contribution to journal › Meeting Abstract › peer-review

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{99c7448a7c39489b96d3e27605039aec,

title = "FDG-PET response in the normal lung for lung cancer patients receiving fractionated radiotherapy and erlotinib",

author = "A. Abravan and I. Knudtsen and H. Eide and O. Brustugun and A. Helland and E. Malinen",

year = "2015",

month = apr,

doi = "10.1016/s0167-8140(15)41159-4",

language = "English",

volume = "115",

pages = "S634--S635",

journal = "Radiotherapy & Oncology",

issn = "0167-8140",

publisher = "Elsevier BV",

number = "Suppl. 1",

}

TY - JOUR

T1 - FDG-PET response in the normal lung for lung cancer patients receiving fractionated radiotherapy and erlotinib

AU - Abravan, A.

AU - Knudtsen, I.

AU - Eide, H.

AU - Brustugun, O.

AU - Helland, A.

AU - Malinen, E.

PY - 2015/4

Y1 - 2015/4

U2 - 10.1016/s0167-8140(15)41159-4

DO - 10.1016/s0167-8140(15)41159-4

M3 - Meeting Abstract

SN - 0167-8140

VL - 115

SP - S634-S635

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

IS - Suppl. 1

M1 - EP-1167

ER -